Skip to main content
IDWeek 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

226. Antimicrobial Novel Agents: Saturday, 12:15 - 1:30 p.m.

Poster Session: Antimicrobial Novel Agents

(2106) Desirability of Outcome Ranking (DOOR): Application to a Phase 3 Registrational Trial Evaluating Sulopenem for Patients with Complicated Intra-abdominal Infection (cIAI)

Saturday, October 14, 2023
12:15 PM – 1:30 PM US ET
Location: Hall B + C

    Presenting Author(s)

  • Steven I. Aronin, MD

    Senior Vice President and Head of Clinical Development
    Iterum Therapeutics
    Old Saybrook, Connecticut, United States

    • Co-Author(s)

  • Michael W. Dunne, MD

    Chief Scientific Officer
    Iterum Therapeutics
    Old Saybrook, CT, United States

  • JG

    Jayanti Gupta, PhD

    Iterum Therapeutics
    Old Saybrook, Connecticut, United States

  • Sailaja Puttagunta, MD

    Chief Medical Officer
    Iterum Therapeutics
    Old Saybrook, Connecticut, United States